中国全科医学 ›› 2025, Vol. 28 ›› Issue (21): 2652-2660.DOI: 10.12114/j.issn.1007-9572.2024.0456

所属专题: 儿科最新文章合辑

• 重点人群关注·儿童健康研究 • 上一篇    下一篇

我国儿童用药政策的量化评价:基于政策建模一致性指数模型

罗金萍1,2,3, 孙嘉颖1,2,3, 牟艺帆1,2,3, 耿铭慧1,2,3, 张宝轩1,2,3, 王康4, 尹文强1,2,3, 陈钟鸣1,2,3, 马东平1,2,3,*()   

  1. 1.261053 山东省潍坊市,山东第二医科大学管理学院
    2.261053 山东省潍坊市,"健康山东"重大社会风险预测与治理协同创新中心
    3.200032 上海市,健康风险预警治理协同创新中心
    4.261000 山东省潍坊市人民医院财务部
  • 收稿日期:2024-10-08 修回日期:2024-12-03 出版日期:2025-07-20 发布日期:2025-06-05
  • 通讯作者: 马东平

  • 作者贡献:

    罗金萍、马东平负责论文的构思与撰写;罗金萍、孙嘉颖负责论文的可行性分析;罗金萍、孙嘉颖、牟艺帆、耿铭慧、张宝轩、王康、尹文强、陈钟鸣、马东平参与了论文的修订;马东平负责论文的质量控制和审查,对文章整体负责,监督管理。

  • 基金资助:
    国家自然科学基金资助项目(72004164)

Quantitative Evaluation of China's Pediatric Drug Policies Based on Policy Modeling Consistency Index Model

LUO Jinping1,2,3, SUN Jiaying1,2,3, MOU Yifan1,2,3, GENG Minghui1,2,3, ZHANG Baoxuan1,2,3, WANG Kang4, YIN Wenqiang1,2,3, CHEN Zhongming1,2,3, MA Dongping1,2,3,*()   

  1. 1. School of Management, Shandong Second Medical University, Weifang 261053, China
    2. "Health Shandong" Severe Social Risk Prevention and Management Synergy Innovation Center, Weifang 261053, China
    3. Collaborative Innovation Center of Social Risks Governance in Health, Shanghai 200032, China
    4. Finance Department of Weifang People's Hospital, Weifang 261000, China
  • Received:2024-10-08 Revised:2024-12-03 Published:2025-07-20 Online:2025-06-05
  • Contact: MA Dongping

摘要: 背景 儿童作为特殊群体受到公众的关注,虽然近年来发布了一系列政策保障儿童用药安全,但仍存在药物适宜品种少、不合理用药等问题,亟需科学合理的儿童用药政策推动其发展。 目的 对我国儿童用药政策文本进行量化评价,为未来的儿童用药政策的制订和完善提供参考,从而推动儿童用药事业的高质量发展。 方法 基于文本挖掘法对2014—2023年国家层面出台的23份儿童用药政策文件进行处理,构建儿童用药政策的政策建模一致性(PMC)指数模型,通过10个一级变量和41个二级变量对我国23项儿童用药政策进行量化评价分析。 结果 23项儿童用药政策的PMC指数均值为5.65,PMC凹陷指数均值为4.35,包括1项优秀级政策、17项良好级政策和5项合格级政策,无完美级政策和不良政策;23项儿童用药政策在政策工具和政策受体上得分较高,在发布机构和政策时效上得分较低。 结论 我国儿童用药政策总体上处于良好水平,可从政策时效、发布机构和政策内容方面进一步完善。

关键词: 卫生政策, 用药政策, 儿童, 政策建模一致性指数模型, 定量评价

Abstract:

Background

Children, as a special group, have received public attention. Although a series of policies have been released in recent years to ensure the safety of children's medication, there are still problems such as fewer suitable varieties of drugs and irrational use of medication, which require scientific and reasonable policies on children's medication to promote their development.

Objective

To quantitatively evaluate China's pediatric drug policy texts and provide reference for the formulation and improvement of future pediatric drug policies.

Methods

Based on the text mining method, 23 pediatric drug policy documents issued at the national level from 2014 to 2023 were processed, the policy modeling consistency (PMC) index model of pediatric drug policy was constructed, and the quantitative evaluation and analysis of China's 23 pediatric drug policies were carried out through 10 primary variables and 41 secondary variables.

Results

The mean value of PMC index of the 23 policies on pediatric drug was 5.65, and the mean value of PMC depression index was 4.35, including 1 excellent-grade policy, 17 good-grade policies and 5 qualified-grade policies, and there were no perfect-grade policies and bad policies. 23 medication policies for children scored high on policy tools and policy receptors and low on publishing organizations and policy timeliness.

Conclusion

China's pediatric drug policy is generally at a good level, and can be further improved in terms of policy timeliness, issuing organization and policy content.

Key words: Health policy, Drug policies, Child, Policy modeling consistency index model, Quantitative evaluation

中图分类号: